FDA Urged to Bar Psoriasis Drug
A federal panel of dermatologists has asked the FDA to avoid approving Tazoral (Allergan), a medication for treating moderate-to-severe psoriasis because of concerns about birth defects and weakened bones. cozaar online The drug’s active ingredient, tazaro-tene, is available as a gel and a cream. The FDA will be considering the panel’s vote when it decides whether [...]





